價格 | 詢價 |
包裝 | 25mg |
最小起訂量 | 25mg |
發(fā)貨地 | 上海 |
更新日期 | 2025-01-30 |
中文名稱:CHIR-99021 (GSK-3抑制劑) | 英文名稱:CHIR-99021 (GSK-3抑制劑) |
有效期: 一年 | 產(chǎn)品類別: MAPK與PI3K/Akt通路 PI3K/Akt Signaling |
產(chǎn)品編號 | 產(chǎn)品名稱 | 產(chǎn)品包裝 | 產(chǎn)品價格 |
SF2708-25mg | CHIR-99021 (GSK-3抑制劑) | 25mg | 2798.00元 |
化學(xué)信息:
化學(xué)名 | 6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile | |
簡稱 | CHIR-99021 | |
別名 |
Chir 99021, Chir-99021, Chir99021, CT 99021, CT-99021, CT99021 |
|
中文名 | N/A | |
化學(xué)式 | C22H18Cl2N8 | |
分子量 | 465.34 | |
CAS號 | 252917-06-9 | |
純度 | 98% | |
溶劑/溶解度 |
Water<1mg/ml; DMSO78mg/ml; Ethanol<1mg/ml |
|
溶液配制 | 5mg加入1.07ml DMSO,或者每4.65mg加入1ml DMSO,配制成10mM溶液。SF2708-10mM用DMSO配制。 |
生物信息:
產(chǎn)品描述 | CHIR-99021 (CT99021)是一種GSK-3α和GSK-3β抑制劑,IC50分別為10nM和6.7nM。 | ||||
信號通路 | PI3K/Akt/mTOR; Stem Cells & Wnt | ||||
靶點 | GSK-3β | GSK-3α | - | - | - |
IC50 | 6.7nM | 10nM | - | - | - |
體外研究 | CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases. Furthermore, CHIR-99021 shows only weak binding to a panel of 22 pharmacologically relevant receptors and little inhibitory activity against a panel of 23 nonkinase enzymes. CHIR-99021 induces the activation of glycogen synthase (GS) in insulin receptor-expressing CHO-IR cells with EC50 of 0.763μM. | ||||
體內(nèi)研究 | Oral administration of CHIR-99021 at 30mg/kg enhances glucose metabolism in a rodent model of type 2 diabetes, with a maximal plasma glucose reduction of nearly 150mg/dl 3-4 hours after administration, while plasma insulin remains at or below control levels. Oral administration of CHIR-99021 at 16 or 48mg/kg 1 hour before oral glucose challenges in ZDF rats significantly improves glucose tolerance with 14% and 33% reduction in plasma glucose at 16mg/kg and 48mg/kg, respectively, and the higher dose of CHIR-99021 also reduces hyperglycemia before the oral glucose challenge. | ||||
臨床實驗 | N/A | ||||
特征 | N/A |
相關(guān)實驗數(shù)據(jù)(此數(shù)據(jù)來自于公開文獻(xiàn),碧云天并不保證其有效性):
酶活性檢測實驗 | |
方法 | N/A |
細(xì)胞實驗 | |
細(xì)胞系 | Insulin receptor-expressing CHO-IR cells; Primary rat hepatocytes |
濃度 | 0.01-10μM |
處理時間 | 30 min |
方法 | CHO-IR cells expressing human insulin receptor are grown to 80% confluence in Hamm's F12 medium with 10% fetal bovine serum and without hypoxanthine. Trypsinized cells are seeded in 6-well plates at 1×106 cells/well in 2ml of medium without fetal bovine serum. After 24h, medium is replaced with 1 ml of serum-free medium containing GSK-3 inhibitor or control (final DMSO concentration <0.1%) for 30 min at 37℃. Cells are lysed and centrifuged 15 min at 4℃/14000g. The activity ratio of GS is calculated as the GS activity in the absence of glucose-6-phosphate divided by the activity in the presence of 5mMol/l glucose-6-phosphate, using the filter paper assay of Thomas et al. |
動物實驗 | |
動物模型 | Female db/db mice; Male ZDF rats |
配制 | HCl salts formulated |
劑量 | 8-48mg/kg |
給藥方式 | oral administration |
產(chǎn)品編號 | 產(chǎn)品名稱 | 包裝 |
SF2708-10mM | CHIR-99021 (GSK-3抑制劑) | 10mM×0.2ml |
SF2708-5mg | CHIR-99021 (GSK-3抑制劑) | 5mg |
SF2708-25mg | CHIR-99021 (GSK-3抑制劑) | 25mg |
— | 說明書 | 1份 |
保存條件:
????????-20℃保存,至少一年有效。5mg和25mg包裝也可室溫保存,至少6個月有效。如果溶于非DMSO溶劑,建議分裝后-80℃保存,預(yù)計6個月內(nèi)有效。
成立日期 | 2007-07-19 (18年) | 注冊資本 | 1000.000000萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 500萬-1000萬 |
主營行業(yè) | 生化試劑,核苷,核苷酸,寡核苷酸,抗體,蛋白組學(xué),生物活性小分子 | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
上海易匯生物科技有限公司
|
2025-01-30 | ||
詢價 |
北京綠源伯德生物科技有限公司
|
2025-01-30 | ||
詢價 |
VIP1年
|
安徽重天生物科技有限公司
|
2025-01-26 |